OMB control number

Guidance for Industry on User Fee Waivers, Reductions, and Refunds for Drug and Biological Products

OMB 0910-0693 · HHS/FDA.

OMB 0910-0693

The information collection supports agency guidance. The guidance provides recommendations for applicants planning to request waivers or reductions in user fees under the Prescription Drug User Fee Act, and describes the types of waivers and reductions permitted under the user fee provisions of the FD&C Act and the procedures for submitting requests for waivers or reductions.

The latest form for Guidance for Industry on User Fee Waivers, Reductions, and Refunds for Drug and Biological Products expires 2020-10-31 and is listed under ICR 201706-0910-016.

All Historical Document Collections

Historical document collections
ReferenceFilingReceivedConcludedAction
201706-0910-016 Extension without change of a currently approved collection 2017-08-17 Approved without change
201503-0910-011 No material or nonsubstantive change to a currently approved collection 2015-03-26 Approved without change
201407-0910-012 Revision of a currently approved collection 2014-07-25 Approved with change
201108-0910-004 New collection (Request for a new OMB Control Number) 2011-08-04 Approved without change

OMB Details

Guidance for Industry: User Fee Waivers, Reductions, and Refunds for Drug and Biological Products

Federal Enterprise Architecture: Health - Consumer Health and Safety

Information collection instruments
FormNameElectronic accessType
Form Form FDA 3971SMALL BUSINESS WAIVER AND REFUND REQUESTFillable FileableForm and instruction

Review document collections for all forms, instructions, and supporting documents - including paper/printable forms.